| Current Price | $118.19 | Mkt Cap | $208.7B |
|---|---|---|---|
| Open | $117.98 | P/E Ratio | 40.39 |
| Prev. Close | $118.19 | Div. (Yield) | $5.20 (4.4%) |
| Daily Range | $117.57 - $118.67 | Volume | 4,411,471 |
| 52-Wk Range | $79.11 - $118.67 | Avg. Daily Vol. | 6,294,199 |
| Current Price | $118.19 | Mkt Cap | $208.7B |
|---|---|---|---|
| Open | $117.98 | P/E Ratio | 40.39 |
| Prev. Close | $118.19 | Div. (Yield) | $5.20 (4.4%) |
| Daily Range | $117.57 - $118.67 | Volume | 4,411,471 |
| 52-Wk Range | $79.11 - $118.67 | Avg. Daily Vol. | 6,294,199 |
The best Bull and Bear pitches based on recency and number of recommendations.
Sold off due to patent cliff concerns and Hep C drug discounts. I believe this is an overreaction and the stock will recover. There is more in the pipeline than the P/E - 13 - would imply.
This mega-cap has made a big run since Express Scripts's announcement that it will take AbbVie's hep C treatment in lieu of Gilead's. Also, an amazing preponderance of CAPS bulls favor this stock beating the market from here -- very interesting. For… More
Read the most recent pitches from players about ABBV.
Recs
Millions2021
(< 20)
Submitted: 7/11/2021 6:45:46 PM :
Start Price:
$115.52
NYSE:ABBV Score:
+1.28
Great growth.
Recs
cwardfs
(< 20)
Submitted: 3/5/2021 7:50:01 PM :
Start Price:
$103.52
NYSE:ABBV Score:
-0.11
This is my biopharmaceutical choice.
Recs
BretterThanMost
(40.95)
Submitted: 2/6/2021 5:27:26 PM :
Start Price:
$78.07
NYSE:ABBV Score:
-1.35
The decision to acquire Allergan to diversify the company's revenue stream away from Humira appears to have been an excellent one and the ongoing absorption of Allergan appears to be going smoothly. Decent growth prospects for sales per share and the current dividend, now at 4.78%, are likely to produce above average total returns over the next decade.
Find the members with the highest scoring picks in ABBV.
GW1000 (88.71) Score: +202.25
The Score Leader is the player with the highest score across all their picks in ABBV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| armydave | 74.16 |
|
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
| pirotta | < 20 | 1/10/2013 |
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
| deliman723 | 64.17 | 1/10/2013 |
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
| concealedweaponR | < 20 | 1/10/2013 |
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
| drjohn432 | < 20 |
|
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
|
valari25 | 97.72 |
|
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment |
|
|
GW1000 | 88.71 |
|
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment |
|
|
mattmmurphy | 70.35 | 1/10/2013 |
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment |
| cooleyly | 48.44 | 1/10/2013 |
|
5Y | $23.54 | +402.08% | +199.83% | +202.25 | 0 Comment | |
|
|
kinosternon | 97.35 | 1/9/2013 |
|
5Y | $23.65 | +399.80% | +201.22% | +198.59 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
